Pyrimidine derivatives useful as Raf kinase inhibitors
Details for Australian Patent Application No. 2008273002 (hide)
International Classifications
Event Publications
11 February 2010 PCT application entered the National Phase
PCT publication WO2009/006389 Priority application(s): WO2009/006389
12 January 2012 Assignment before Grant
Sunesis Pharmaceuticals, Inc.; Biogen Idec MA Inc. The application has been assigned to Millennium Pharmaceuticals, Inc.; Sunesis Pharmaceuticals, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008273017-Heterocyclic compounds useful as Raf kinase inhibitors
2008272991-Method of determining electrical anisotropy in a subsurface formation
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser